Navigation Links
Novel genetic blood test

An international team of researchers is developing a new genetic blood test that allows a much closer match between donors and recipients//. The Bloodchip gives more details in the result than the existing tests. The current tests look for blood types while the Bloodchip looks for DNA “signatures”.

A spokeswoman for the National Blood Service, which is helping develop the test, said, “It could be "a lifesaver" for those needing regular transfusions. It is hoped the test could be of particular benefit to people with blood conditions such as sickle cell anaemia, haemophilia, thalassaemias and leukaemia.”

The developers of Biochip warn that patients with these conditions, who require routine blood transfusions, can develop life-threatening side effects on receiving not a properly matched blood.

3,000 healthy blood samples are being tested with Biochip as a "proof of principle". The results reveal its accuracy compared to the current tests. This was done with the intention of getting European health and safety approval.

The existing serological tests identify the blood group; A, B, AB or O and the rhesus antigen, thus Rh positive or negative. Whereas, the Biochip test identifies nearly 9 other possible differences in the blood, like the Duffy system - blood can be Duffy A or Duffy B.

When differences in each system are considered, the test could detect around 116 blood type DNA "signatures" Thee DNA extracted from blood samples are tested on glass microscopic slides. Chemicals are added to the DNA on the slide, resulting in reaction that gives out fluorescent colours. A scanner in which the slide is placed determines blood types.

Professor Neil Avent, director of University of West England's Centre for Research in Biomedicine who has been involved in the research, said: "Blood transfusions are inherently safe. But with the compatibility between the donor and the recipient being tested using serological tec hniques, there is a significant section of the population that suffer serious illness and side effects after receiving multiple transfusions of blood that is not a perfect match."

"These patients over time develop antibodies that reject imperfectly matched blood transfusions, a process known as alloimmunisation, which can lead to serious illness and life-threatening side effects." "Bloodchip has been developed with these communities in mind."

Professor Marion Scott, national director of research at the UK National Blood Service, said: "The Bloodchip test will literally be a lifesaver for those who suffer from illnesses that require multiple blood transfusions such as haemophilia, sickle cell disease and thalassaemias.

"Sickle cell disease and thalassaemias are particularly prevalent in those from African, Caribbean, Eastern Mediterranean, Middle East and Asian backgrounds and both can be life-threatening.

"The Bloodchip test will be of enormous benefit in ensuring those with these disorders receive perfectly matched blood to enable them to better manage their conditions."

A consortium called Bloodgen has been formed by scientists from the UK, Germany, Sweden, Spain, the Czech Republic and the Netherlands, to develop the test . Progenika Biopharma in Spain will manufacture the Biochip.
YT
'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to ... a new, often overlooked aspect of head lice: the parasite’s ability to live away from ... common occurrence, but a necessary one in the event that lice have simply gotten out ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: